Correlation Between Vincerx Pharma and Adagene
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Adagene, you can compare the effects of market volatilities on Vincerx Pharma and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Adagene.
Diversification Opportunities for Vincerx Pharma and Adagene
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vincerx and Adagene is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Adagene go up and down completely randomly.
Pair Corralation between Vincerx Pharma and Adagene
Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the Adagene. In addition to that, Vincerx Pharma is 5.31 times more volatile than Adagene. It trades about -0.02 of its total potential returns per unit of risk. Adagene is currently generating about -0.11 per unit of volatility. If you would invest 201.00 in Adagene on October 20, 2024 and sell it today you would lose (17.00) from holding Adagene or give up 8.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vincerx Pharma vs. Adagene
Performance |
| Timeline |
| Vincerx Pharma |
| Adagene |
Vincerx Pharma and Adagene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vincerx Pharma and Adagene
The main advantage of trading using opposite Vincerx Pharma and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.| Vincerx Pharma vs. Spero Therapeutics | Vincerx Pharma vs. Bolt Biotherapeutics | Vincerx Pharma vs. Coherus BioSciences | Vincerx Pharma vs. Applied Therapeutics |
| Adagene vs. Aerovate Therapeutics | Adagene vs. Acrivon Therapeutics, Common | Adagene vs. Rezolute | Adagene vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |